Autoimmune disorder of musculoskeletal system
MONDO:0000589A hypersensitivity reaction type II disease that involves the musculoskeletal system.
Also known as: musculoskeletal system autoimmune disease, musculoskeletal system hypersensitivity reaction type II disease
758 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
HPV vaccine shows promise for girls on Immune-Suppressing drugs
⭐️ VACCINE ⭐️ CompletedThis study looked at whether the HPV vaccine works in girls aged 9 to 17 who are taking medicines that weaken their immune system, such as after an organ transplant or for diseases like lupus. The goal was to see if their bodies produce enough antibodies to protect against HPV. T…
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:36 UTC
-
Shingles vaccine study shows promise for rheumatoid arthritis patients
⭐️ VACCINE ⭐️ CompletedThis study looked at how safe and effective two shingles vaccines (Zostavax and Shingrix) are in people with rheumatoid arthritis who are taking the drug abatacept. About 154 adults took part, and researchers measured their immune response and any side effects. The goal was to se…
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:29 UTC
-
New booster aims to shield the vulnerable from COVID-19
⭐️ VACCINE ⭐️ CompletedThis study tested an extra dose of the HIPRA COVID-19 vaccine in 241 adults with conditions like HIV, kidney disease, or autoimmune disorders that weaken the immune system. The goal was to see if the booster raises antibody levels against virus variants and remains safe. Research…
Phase: PHASE2, PHASE3 • Sponsor: Hipra Scientific, S.L.U • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 18:38 UTC
-
Your plate may fight psoriatic arthritis: diet study tests food as medicine
Disease control CompletedThis study investigates whether changing diet can reduce disease activity in people with psoriatic arthritis. Participants are randomly assigned to one of two diets: one focusing on which foods are eaten, and another limiting daily calorie intake. The trial lasts 24 weeks and inc…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Rheumatoid arthritis drug baricitinib put to the test against TNF blockers in major safety trial
Disease control CompletedThis completed Phase 4 study compared the safety of baricitinib (a daily pill) to TNF inhibitors (injections) in over 2,600 adults with rheumatoid arthritis. The main goal was to see if baricitinib had a higher risk of blood clots. Participants had to be at least 60, have a histo…
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Short exercise program may cut heart risk in arthritis patients
Disease control CompletedThis completed study tested whether a 6-week cardiac rehabilitation program (aerobic and resistance exercises) could improve heart disease risk, blood pressure, and arthritis activity in 40 people with both rheumatoid arthritis and high blood pressure. Participants were randomly …
Phase: NA • Sponsor: Kayseri City Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New arthritis drug candidate SHR-3045 tested in healthy volunteers
Disease control CompletedThis Phase 1 study tested a single injection of SHR-3045 in 16 healthy adults to see if it is safe and how the body processes it. The drug is being developed as a potential treatment for rheumatoid arthritis, an autoimmune disease that causes joint pain and swelling. Because this…
Phase: PHASE1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Real-World data on RA drug peficitinib: safety check in 3,000 patients
Disease control CompletedThis study looked at how safe and effective peficitinib is for people with rheumatoid arthritis (RA) in everyday medical practice. About 3,000 patients who were starting peficitinib for the first time took part. Researchers tracked side effects and measured disease activity using…
Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New Stem-Free shoulder implant shows promise in european study
Disease control CompletedThis study followed 152 people who received the Sidus Stem-Free Shoulder implant for severe shoulder pain and disability due to arthritis or other joint diseases. The implant is designed to replace the shoulder joint without a long stem, potentially preserving more bone. Research…
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New rheumatoid arthritis drug candidate passes first safety check in healthy volunteers
Disease control CompletedThis early-stage trial tested the safety of a new drug called SHR-3045 in 40 healthy adults. The study was randomized, double-blind, and placebo-controlled, meaning some participants got the drug and some got a dummy shot. The main goal was to see if the drug causes any side effe…
Phase: PHASE1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug shows promise for Long-Term psoriatic arthritis control
Disease control CompletedThis study looked at the long-term safety and effectiveness of bimekizumab in adults with active psoriatic arthritis. Over 1,100 people who completed earlier studies received the drug and were monitored for side effects and disease symptoms. The goal was to see if bimekizumab rem…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug shows promise in taming psoriatic arthritis flares
Disease control CompletedThis Phase 3 study tested guselkumab, a drug given by injection, in 741 adults with active psoriatic arthritis. The goal was to see if it reduces joint pain and swelling. Participants received either guselkumab or a placebo. The main measure was a 20% improvement in arthritis sym…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a gut bacteria booster ease rheumatoid arthritis?
Disease control CompletedThis pilot study tested whether a butyrate supplement, a type of short-chain fatty acid, could change the gut microbiome and immune responses in people with rheumatoid arthritis who didn't respond well to methotrexate. Twenty participants took the supplement for up to two months.…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Real-world filgotinib study tracks arthritis control over 2 years
Disease control CompletedThis study followed 155 French adults with moderate-to-severe rheumatoid arthritis who were prescribed filgotinib (Jyseleca) for the first time. Over two years, researchers measured how many patients stayed on the drug and how well it controlled their disease activity. The goal w…
Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New pill could ease rheumatoid arthritis pain
Disease control CompletedThis study tested an experimental oral drug called LY3871801 in 164 adults with moderately-to-severe rheumatoid arthritis. The goal was to see if it reduces joint swelling and pain better than a placebo. The trial is complete, and results will help decide if further testing is wa…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Daily painkillers may shield spines in arthritis patients on biologics
Disease control CompletedThis study looked at whether taking NSAIDs every day, instead of only when needed, can prevent spine damage in people with ankylosing spondylitis who are also receiving anti-TNF therapy. 188 adults participated in this Phase 3 trial. The goal was to see if continuous NSAID use re…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New combo therapy targets both joint pain and obesity in PsA patients
Disease control CompletedThis study tested whether adding a weight-loss drug (tirzepatide) to a standard arthritis drug (ixekizumab) helps people with psoriatic arthritis who are overweight or obese. 279 adults with active psoriatic arthritis and a BMI of 27 or higher took part. The goal was to see if th…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Robotic knee surgery put to the test in 252-Patient study
Disease control CompletedThis study looked at whether using a robotic system (ROSA) during knee replacement surgery leads to more accurate implant placement compared to traditional methods. It included 252 adults with knee pain, arthritis, or deformities who were already scheduled for knee replacement. R…
Phase: NA • Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for arthritis sufferers: filgotinib shows promise in korean trial
Disease control CompletedThis study tested the drug filgotinib (Jyseleca) in 118 Korean adults with rheumatoid arthritis. The goal was to see how many patients experienced at least a 20% improvement in symptoms after 12 weeks of treatment. The trial is complete, and results will help determine if filgoti…
Phase: PHASE4 • Sponsor: Eisai Korea Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Antidepressant shows promise for arthritis relief in new trial
Disease control CompletedThis phase 3 trial tested whether adding paroxetine, an antidepressant, to standard methotrexate therapy can better control rheumatoid arthritis. 100 adults with active RA took part. The main goal was to see if the combination lowers disease activity scores more than methotrexate…
Phase: PHASE3 • Sponsor: Mostafa Bahaa • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Skyrizi under the microscope: Real-World safety data on over 2,300 patients
Disease control CompletedThis study tracked over 2,300 adults in Korea who were prescribed Skyrizi (risankizumab) for moderate to severe plaque psoriasis or psoriatic arthritis. Researchers monitored side effects and symptom changes for 52 weeks during routine doctor visits. The goal was to confirm the d…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New arthritis drug shows promise in major trial
Disease control CompletedThis study tested an injectable drug called CT-P13 in 192 adults with moderate-to-severe rheumatoid arthritis. The goal was to see if it reduces joint pain and swelling better than a placebo. Participants received either the drug or a dummy shot, and researchers measured improvem…
Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New psoriasis drug shows promise in major trial
Disease control CompletedThis study tested a new drug called bimekizumab in 567 adults with moderate to severe plaque psoriasis. Participants received either bimekizumab, a placebo, or another active drug. The main goal was to see how well bimekizumab cleared skin lesions after 16 weeks. Results showed s…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug bimekizumab shows promise in clearing psoriasis in phase 3 trial
Disease control CompletedThis phase 3 study tested bimekizumab, a drug given by injection, against a placebo in 435 adults with moderate to severe plaque psoriasis. The main goal was to see how many people achieved at least 90% skin clearing after 16 weeks. The trial also looked at complete clearing and …
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug VIS171 tested in humans for first time – could it tame autoimmune disease?
Disease control CompletedThis early-phase trial tested a new drug called VIS171 in 61 people: first in healthy volunteers, then in patients with autoimmune diseases. The main goal was to check safety and how the body processes the drug. No results on whether it actually helps the disease are available ye…
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Ultrasound may spot arthritis Flare-Ups before symptoms start
Disease control CompletedThis study tested whether ultrasound could detect signs of rheumatoid arthritis (RA) relapse before symptoms appear in patients treated with rituximab. Thirty adults with RA who had not responded to at least one TNF-blocking drug were included. Researchers used ultrasound to meas…
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug NTR-1011 tested for autoimmune diseases
Disease control CompletedThis early-stage trial tested the safety of a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The study aimed to find a safe dose and see how the drug behaves in the body. It is a first step toward possibly developing a new treatment f…
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug combo shows promise for Tough-to-Treat psoriatic arthritis
Disease control CompletedThis study tested whether combining two drugs (guselkumab and golimumab) works better than one drug alone for people with active psoriatic arthritis who didn't get enough relief from previous TNF-alpha blockers. 91 adults took part. The goal was to see if the combo could help mor…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Arthritis patients may swap IV infusions for convenient at-home shots
Disease control CompletedThis study tested whether people with rheumatoid arthritis, psoriatic arthritis, or spine arthritis could safely switch from receiving infliximab through an IV infusion at a clinic to giving themselves a simple shot under the skin at home. 22 adults who were already stable on IV …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a natural compound ease rheumatoid arthritis?
Disease control CompletedThis study tested a compound called 2-HOBA in 32 adults with rheumatoid arthritis. Participants took either 2-HOBA or a placebo three times a day for 4 weeks. The goal was to see if 2-HOBA is safe and reduces markers of inflammation. This early research helps plan larger future s…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a second drug stop the body from rejecting arthritis treatment?
Disease control CompletedThis study looked at whether adding methotrexate to adalimumab (a biologic drug) reduces the chance that the body makes antibodies against adalimumab in people with ankylosing spondylitis. About 110 adults with active disease who did not respond well to NSAIDs took part. The goal…
Phase: PHASE4 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New shoulder implant shows promise in early study
Disease control CompletedThis study tested a new shoulder implant called the Catalyst CSR System in 87 people with shoulder arthritis or bone damage. The implant is designed to preserve more natural bone than traditional replacements. Researchers measured pain, movement, and implant safety over two years…
Phase: NA • Sponsor: Catalyst OrthoScience • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New biologic KD6005 tested in first human trial for rheumatoid arthritis
Disease control CompletedThis early-stage trial tested a new biologic drug called KD6005 in 73 people: first in healthy volunteers, then in patients with rheumatoid arthritis. The main goal was to check safety and how the body processes the drug. It is too soon to know if KD6005 works, but this study is …
Phase: PHASE1 • Sponsor: Shanghai Kanda Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a Heart-Healthy diet tame rheumatoid arthritis?
Disease control CompletedThis completed study looked at whether the DASH diet, known for lowering blood pressure, can help people with rheumatoid arthritis. Forty-nine adults with active disease followed a personalized DASH diet for 12 weeks. Researchers measured changes in disease activity, pain, and in…
Phase: NA • Sponsor: Istanbul Health and Technology University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug XKH004 shows promise in phase 3 trial for back pain from ankylosing spondylitis
Disease control CompletedThis Phase 3 trial tested a new drug called XKH004 in 323 adults with moderate-to-severe active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. The drug works by blocking two inflammatory proteins, IL-17A and IL-17F. Participants received either X…
Phase: PHASE3 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study: can upadacitinib ease back pain in axial spondylarthritis?
Disease control CompletedThis study looked at how well upadacitinib, an anti-inflammatory pill, controls pain in people with axial spondylarthritis (axSpA), a condition causing chronic back pain. Over 700 adults from 19 countries took the drug as prescribed by their doctors and were followed for 12 month…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New shot could ease back pain for ankylosing spondylitis patients
Disease control CompletedThis study tested a drug called AK111 in 510 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either AK111 or a placebo as a shot under the skin over 48 weeks. The main goal was to see if AK111 improves symp…
Phase: PHASE3 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New pill shows promise for treating spinal arthritis in large trial
Disease control CompletedThis study tested a daily pill called upadacitinib in 734 adults with axial spondyloarthritis, a type of arthritis that causes pain and stiffness in the spine. The drug was compared to a placebo to see if it could reduce symptoms and control the disease. Results showed that upada…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
RINVOQ tested in Real-World study for back pain disease
Disease control CompletedThis study tested the drug RINVOQ in 69 adults with ankylosing spondylitis, a type of arthritis that mainly affects the spine. Participants took RINVOQ as prescribed by their doctor and were followed for up to a year. The goal was to see how safe and effective the drug is in real…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Massive korean study confirms Upadacitinib's Real-World safety
Disease control CompletedThis study looked at how safe and effective upadacitinib is for Korean patients with rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, or psoriatic arthritis. Over 2,300 adults took the drug as prescribed by their doctor and were followed for about 28 weeks. Resear…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Head-to-Head: which drug works better for psoriatic arthritis in the real world?
Disease control CompletedThis study looked at 70 people with psoriatic arthritis to compare two drug types: upadacitinib and IL-17 inhibitors. Researchers tracked joint and skin symptoms over 24 weeks in routine care. The goal is to see which works better in real life, helping doctors personalize treatme…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug shows promise for controlling psoriatic arthritis symptoms
Disease control CompletedThis study tested a drug called bimekizumab in 852 adults with active psoriatic arthritis, a condition causing joint pain, swelling, and skin patches. Participants received either bimekizumab, a placebo, or an existing treatment (adalimumab). The main goal was to see if bimekizum…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug bimekizumab shows promise for psoriatic arthritis in phase 3 trial
Disease control CompletedThis Phase 3 trial tested bimekizumab, a drug given by injection, against a placebo in 400 adults with active psoriatic arthritis who had not responded well to TNF-alpha inhibitors. The study aimed to see if bimekizumab could reduce joint pain and swelling and improve daily funct…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Which biologic works best after Anti-TNF failure? study seeks answers
Disease control CompletedThis study looked at 300 adults with active rheumatoid arthritis whose first anti-TNF treatment stopped working. Researchers compared two strategies: switching to a different type of biologic drug or trying a second anti-TNF. The goal was to see which approach better controls the…
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Biosimilar switch works for most patients in Real-World study
Disease control CompletedThis study tested what happens when patients with rheumatoid arthritis, Crohn's disease, or eye inflammation switch from the original drug Remicade to its lower-cost biosimilar Inflectra. Over 260 adults who had been on Remicade for at least 4 months were switched. The main goal …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New injection aims to retrain immune cells to fight arthritis
Disease control CompletedThis early study tested a new drug called EF-M2 (Immutalon) in 48 adults with moderate-to-severe rheumatoid arthritis. The drug is designed to shift immune cells from a pro-inflammatory to an anti-inflammatory state. Participants received injections for 4 weeks, and researchers m…
Phase: PHASE1, PHASE2 • Sponsor: S.LAB (SOLOWAYS) • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New biologic injection shows promise for psoriatic arthritis in phase 3 trial
Disease control CompletedThis phase 3 trial tested a single injection of tildrakizumab against placebo in 508 adults with active psoriatic arthritis who had previously used anti-TNF drugs. The main goal was to see if more people achieved at least a 20% improvement in joint symptoms. The study is now comp…
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New daily pill shows promise for rheumatoid arthritis in early trial
Disease control CompletedThis Phase 2 trial tested Proximod, a daily pill that calms the immune system, in 179 adults with moderate-to-severe rheumatoid arthritis who had not responded well to standard treatments. Participants took either 5 mg, 10 mg, or a placebo daily for three months, with one month o…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Higher dose offers new hope for psoriasis patients who stopped responding to standard therapy
Disease control CompletedThis study tested a higher dose (10 mg/kg every 8 weeks) of the drug TA-650 in 51 adults with psoriasis who had initially improved on the standard dose of Remicade but later lost that benefit. The goal was to see if the increased dose could again reduce skin symptoms. Participant…
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New injection for rheumatoid arthritis enters first human safety tests
Disease control CompletedThis early-stage study tested a new biologic drug called SOL-116 in 56 healthy volunteers and people with rheumatoid arthritis. The main goal was to check safety and how the body processes the drug, not whether it works. Participants received a single injection of SOL-116 or a pl…
Phase: PHASE1 • Sponsor: Lipum AB • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Biosimilar arthritis drug shows promise in small study
Disease control CompletedThis study tested a biosimilar version of the drug infliximab (made by Pfizer) in 77 people with rheumatoid arthritis. The goal was to see how safe and effective it is in real-world use. Participants received the drug by IV infusion, and researchers tracked side effects and disea…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a higher dose of infliximab tame stubborn rheumatoid arthritis?
Disease control CompletedThis study tested whether increasing the dose of infliximab (a drug that blocks inflammation) helps people with active rheumatoid arthritis who did not improve enough with methotrexate alone. 327 adults received one of three doses (3, 6, or 10 mg/kg) by IV infusion over nearly a …
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New combo therapy for rheumatoid arthritis shows promise in early trial
Disease control CompletedThis study tested whether adding an experimental drug called MP-435 to standard methotrexate treatment helps people with rheumatoid arthritis who don't get enough relief from methotrexate alone. 112 adults took either MP-435 or a placebo (dummy pill) plus their usual methotrexate…
Phase: PHASE2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a blood clot drug ease arthritis pain?
Disease control CompletedThis study tested whether cilostazol, a drug normally used for leg pain from blocked arteries, can help control rheumatoid arthritis when added to standard medications. 70 adults with moderate to severe arthritis took either cilostazol plus their usual drugs or just their usual d…
Phase: PHASE2, PHASE3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug shows promise for back pain from ankylosing spondylitis
Disease control CompletedThis study tested a drug called bimekizumab in 332 adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. Participants received either the drug or a placebo injection. The goal was to see if the drug could reduce symptoms like pain and…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New shoulder implant shows promise for arthritis patients
Disease control CompletedThis study tested a new shoulder implant called PyroTITAN HRA in 156 people with arthritis. The implant resurfaces the ball part of the shoulder joint to relieve pain and improve function. Researchers tracked how long the device lasted and whether it caused problems, aiming to se…
Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Massive study reveals best arthritis drug combos for patients
Disease control CompletedThis study looked at over 9,000 people with rheumatoid arthritis to compare how well different treatments work in everyday medical practice. Researchers compared drugs like TNF inhibitors and tofacitinib, given alone or with methotrexate, to see which combination controls disease…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a protein derived from vitamin d tame chronic inflammation?
Disease control CompletedThis study tested a protein called GcMAF, which is made from vitamin D-binding protein and is thought to calm the immune system. Researchers gave it to 120 adults with chronic inflammatory conditions like rheumatoid arthritis or cystitis that didn't improve with standard treatmen…
Phase: PHASE1, PHASE2 • Sponsor: S.LAB (SOLOWAYS) • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Gum treatment may ease arthritis symptoms, study finds
Disease control CompletedThis study looked at whether treating gum disease (periodontitis) can reduce the severity of rheumatoid arthritis (RA) in people who have both conditions. Researchers enrolled 22 adults with RA and gum disease, providing periodontal treatment and measuring changes in RA activity …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug shows promise for spine arthritis in chinese patients
Disease control CompletedThis study tested a new drug, netakimab, in 113 Chinese adults with active ankylosing spondylitis, a type of arthritis that causes back pain and stiffness. The goal was to see if netakimab works better than a placebo (a dummy treatment) at reducing symptoms. Participants received…
Phase: PHASE3 • Sponsor: SPH-BIOCAD (HK) Limited • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New pill for rheumatoid arthritis enters first human tests
Disease control CompletedThis early-stage trial tested ARD-885, a new oral drug that targets two proteins involved in inflammation, in 94 healthy volunteers and people with rheumatoid arthritis. The main goal was to check safety and how the body processes the drug. Researchers gave single and multiple do…
Phase: PHASE1 • Sponsor: Artivila (Shenzhen) Innovation Center, Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo therapy shows promise for early psoriatic arthritis patients
Disease control CompletedThis study tested whether adding GOLimumab to methotrexate works better than methotrexate alone for people with very early psoriatic arthritis (PsA). 84 adults with active PsA diagnosed within the last 2 years took part. The main goal was to see if the combination improved diseas…
Phase: PHASE3 • Sponsor: The Leeds Teaching Hospitals NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Massive study tests everyday supplements against autoimmune disease and aching knees
Disease control CompletedThis large study looked at whether taking daily vitamin D or fish oil supplements could lower the risk of developing autoimmune diseases (like rheumatoid arthritis), reduce signs of inflammation in the blood, and ease chronic knee pain. Over 25,000 adults without prior cancer or …
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New antibody drug shows promise in early arthritis trial
Disease control CompletedThis early-stage study tested two versions of an experimental drug called ianalumab in 48 adults with active rheumatoid arthritis. The goal was to see if the two forms are similar enough in safety and how the body processes them. Participants received multiple injections, and res…
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New arthritis drug candidate AZD6912 begins first human safety tests
Disease control CompletedThis early-stage trial tested a single dose of the experimental drug AZD6912 in 40 healthy adults to see if it is safe and how the body processes it. The study is a first step toward possibly treating rheumatoid arthritis, but it does not involve people with the disease. Results …
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Steroid-Free hope for arthritis patients?
Disease control CompletedThis study tested two methods to help people with rheumatoid arthritis stop taking steroids (prednisone) safely. 102 adults with low disease activity or remission were given either a gradual dose reduction or a replacement with hydrocortisone. The goal was to see which approach a…
Phase: PHASE4 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Knee implant showdown: which one works better?
Disease control CompletedThis study compared two types of knee implants—the Vanguard Cruciate Retaining and the AGC Total Condylar—in 150 patients with knee arthritis. The goal was to see which implant provides better pain relief and function after knee replacement surgery. Patients were followed for sev…
Phase: NA • Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Study tests if starting stronger drugs earlier tames psoriatic arthritis
Disease control CompletedThis completed trial tested whether starting stronger medications early helps people with moderate to severe psoriatic arthritis more than the usual step-up approach. 192 adults were randomly assigned to standard care, early combination disease-modifying drugs, or early TNF inhib…
Phase: PHASE4 • Sponsor: University of Oxford • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a common diabetes drug protect PsA Patients' hearts?
Disease control CompletedThis pilot study tested whether adding metformin to standard care can slow the buildup of plaque in the carotid arteries of people with psoriatic arthritis (PsA) who do not have diabetes. Twenty-four participants with PsA and existing carotid plaque were randomly assigned to take…
Phase: PHASE4 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Anti-Ulcer drug shows promise for arthritis relief
Disease control CompletedThis study tested whether rebamipide, a drug normally used for stomach ulcers, can help control rheumatoid arthritis when added to standard methotrexate therapy. Sixty adults with active arthritis took either rebamipide or a placebo three times daily. Researchers measured joint p…
Phase: PHASE1, PHASE2 • Sponsor: October 6 University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New pill shows promise for long-term rheumatoid arthritis control
Disease control CompletedThis study looked at the long-term safety and effectiveness of a daily pill called ABX464 in 40 adults with moderate to severe rheumatoid arthritis. Participants had already completed 12 weeks of treatment in an earlier study. The goal was to see if ABX464 can help keep the disea…
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New IV drug shows promise for stiff spine disease
Disease control CompletedThis Phase 3 trial tested golimumab, an anti-inflammatory biologic, given as an IV infusion to 208 people with active ankylosing spondylitis. Participants received either golimumab or a placebo. The main goal was to see if more people on golimumab had at least a 20% improvement i…
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Robot-Assisted knee surgery shows promise in alignment study
Disease control CompletedThis study tested a robotic system called CORI that helps surgeons plan and perform knee replacement surgery. The goal was to see if the robot helps place the new knee joint more accurately. 126 adults who needed a partial or total knee replacement took part. The results showed t…
Phase: NA • Sponsor: Smith & Nephew, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New program aims to cut heart risk in rheumatoid arthritis patients
Disease control CompletedThis study tested a program to help people with rheumatoid arthritis (RA) get their cholesterol checked and treated. Many RA patients are at higher risk for heart attacks and strokes but often miss out on proper screening. The program used peer coaches and educational materials t…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Head-to-Head: which biologic works better for tough psoriatic arthritis?
Disease control CompletedThis study tested two biologic drugs, secukinumab and ustekinumab, in 119 adults with active psoriatic arthritis who had not responded to or could not tolerate TNFα-inhibitor treatment. The main goal was to see which drug better improved physical function over 28 weeks. Researche…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
4-Year arthritis drug study shows promise for kids
Disease control CompletedThis study looked at the long-term safety and effectiveness of the drug secukinumab in children with two types of juvenile idiopathic arthritis: juvenile psoriatic arthritis and enthesitis related arthritis. Fifty-five children who had already completed a previous study continued…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New combo therapy shows promise for Tough-to-Treat rheumatoid arthritis
Disease control CompletedThis study tested whether adding nipocalimab to the standard drug certolizumab works better than certolizumab alone for people with active rheumatoid arthritis. It involved 103 adults who still had moderate to severe symptoms despite trying other advanced treatments. The main goa…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New study shows tofacitinib helps control psoriatic arthritis in daily life
Disease control CompletedThis study looked at how well the drug tofacitinib works for people with psoriatic arthritis in everyday medical practice. Over 12 months, researchers tracked 116 adults to see if the drug reduced disease activity and improved quality of life. The goal was to understand real-worl…
Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New oral drug shows promise in early arthritis trial
Disease control CompletedThis study tested a new oral medication called LW402 in 72 adults with moderate to severe rheumatoid arthritis who were already taking methotrexate. Participants received either LW402 or a placebo for 12 weeks to see if the drug could reduce joint swelling and pain. The goal was …
Phase: PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could your own fat cells tame rheumatoid arthritis?
Disease control CompletedThis early-phase trial tested a single infusion of stem cells taken from the patient's own belly fat in 15 adults with active rheumatoid arthritis. The main goal was to see if the treatment is safe over 12 months. Researchers also looked at whether it could lower inflammation mar…
Phase: PHASE1, PHASE2 • Sponsor: Hope Biosciences LLC • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New pill could ease psoriatic arthritis pain
Disease control CompletedThis study tested an oral drug called upadacitinib (RINVOQ) against a placebo and an injected drug (adalimumab/Humira) in 1705 people with active psoriatic arthritis who had not responded well to standard non-biologic treatments. The goal was to see if upadacitinib reduces joint …
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Smartphone app could help RA patients stay ahead of flares
Disease control CompletedThis study tested a smartphone app and a web-based dashboard to help people with rheumatoid arthritis track their symptoms between doctor visits. 190 participants used the app to answer daily questions about pain and function, while study staff monitored the data and connected pa…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:17 UTC
-
New pill for rheumatoid arthritis passes first safety check in small study
Disease control CompletedThis early-stage study tested a new oral drug called SAR441566 in 10 healthy Japanese men to see how safe it is and how the body processes it. The drug is being developed for rheumatoid arthritis, an autoimmune disease that causes joint pain and swelling. The study only looked at…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 18:07 UTC
-
New knee implant tested for better mobility and longevity
Disease control CompletedThis study tested the DePuy LCS Complete mobile-bearing total knee system in 241 people needing knee replacement due to arthritis. The goal was to see how well the implant and surgical tools work during and after surgery. Researchers measured implant survival, knee function, and …
Phase: PHASE4 • Sponsor: DePuy International • Aim: Disease control
Last updated Jun 26, 2026 16:51 UTC
-
New pill shows promise for Tough-to-Treat psoriatic arthritis
Disease control CompletedThis phase 3 study tested upadacitinib, an oral anti-inflammatory drug, in 642 adults with active psoriatic arthritis who had not responded well to at least one biologic treatment. Participants received either 15 mg or 30 mg of upadacitinib daily or a placebo. The main goal was t…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 26, 2026 16:42 UTC
-
New study checks how well RA drug works in real life
Disease control CompletedThis study looked at how well the drug tocilizumab (Actemra) works for people with moderate to severe rheumatoid arthritis in everyday medical practice. Researchers followed 322 adults for 12 months after starting treatment. The main goals were to see how many patients achieved l…
Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 26, 2026 16:19 UTC
-
Psoriasis drug OTEZLA tested in everyday use
Disease control CompletedThis completed study observed over 1,000 people with psoriasis who were prescribed OTEZLA (apremilast) for the first time. Researchers tracked side effects, symptom improvement, and quality of life over several years. The goal was to see how well the drug works in real-world sett…
Sponsor: Amgen • Aim: Disease control
Last updated Jun 26, 2026 14:49 UTC
-
Blood filter shows promise for autoimmune patients
Disease control CompletedThis study looked at a device called GLOBAFFIN that filters antibodies from the blood to help people with autoimmune diseases. It involved 34 adults and measured how much harmful antibodies were removed and if patients felt better. The goal was to see if the device is safe and wo…
Phase: NA • Sponsor: Fresenius Medical Care Deutschland GmbH • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC
-
New shoulder implant MIRAI put to the test in 76 patients
Disease control CompletedThis study followed 76 adults who received a total shoulder replacement using the MIRAI modular prosthesis. Researchers measured how well the shoulder functioned and how stable the implant was over five years. The goal was to see if the implant helps patients move better and last…
Sponsor: Permedica spa • Aim: Disease control
Last updated Jun 26, 2026 12:51 UTC
-
Psoriatic arthritis drug apremilast tracked for two years in Real-World study
Disease control CompletedThis study followed 526 adults with active psoriatic arthritis who were already prescribed apremilast (Otezla) by their doctors. Researchers observed them for up to 100 weeks to see how well the drug controlled their symptoms in everyday practice. The goal was to gather long-term…
Sponsor: Amgen • Aim: Disease control
Last updated Jun 26, 2026 12:42 UTC
-
Canadian study checks how well RA drug works in daily life
Disease control CompletedThis completed study followed 413 Canadian adults with moderate to severe rheumatoid arthritis who were prescribed upadacitinib by their doctors. Researchers tracked how well the drug controlled symptoms like joint pain and stiffness over 24 months. The goal was to see if the dru…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 26, 2026 12:41 UTC
-
MRI could spot rheumatoid arthritis months earlier
Diagnosis CompletedThis study looked at whether an MRI scan can help doctors diagnose rheumatoid arthritis (RA) sooner in people with joint swelling. 75 adults with early symptoms were given an MRI and followed for a year. The goal was to see if MRI findings could predict who would develop RA, allo…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
New scale could help predict fall risk for hospital patients in turkey
Diagnosis CompletedThis study tested a Turkish version of the Johns Hopkins In-Room Independence Scale, which measures a patient's ability to move, use the toilet, and think clearly while in their hospital room. Researchers worked with 100 adults who had conditions like stroke, Parkinson's, or ampu…
Sponsor: Sisli Hamidiye Etfal Training and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New PET tracer aims to light up hidden infections
Diagnosis CompletedThis early study tested a new radioactive tracer called 18F-FDS in 16 people with suspected bacterial or fungal infections. The tracer is designed to light up infection sites on PET/CT scans, helping doctors see exactly where an infection is. The goal was to check how the tracer …
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
New PET scan technique aims to sniff out hidden infections
Diagnosis CompletedThis early study tested whether a special PET scan using a radioactive form of vitamin B9 (11C-PABA) can help doctors see infections deep inside the body. Researchers scanned 13 healthy people and patients with known or suspected infections. The goal was to see if this method can…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Two-Minute sweat test could spot hidden nerve damage
Diagnosis CompletedThis study tested a device called SUDOSCAN, which measures sweat function in just two minutes, to see if it can detect small fiber nerve damage in people with autoimmune diseases (like lupus or rheumatoid arthritis) or unexplained pain. Researchers enrolled 139 adults and compare…
Phase: NA • Sponsor: Hôpital Européen Marseille • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New knee tensioner aims to improve replacement outcomes
Symptom relief CompletedThis study is testing a device called the CORI™ KNEE TENSIONER, which helps surgeons balance the knee during total knee replacement surgery. Fifty adults who need a knee replacement will have the surgery using this device, and their recovery and quality of life will be tracked fo…
Phase: NA • Sponsor: Smith & Nephew, Inc. • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
App eases psoriasis burden in landmark trial
Symptom relief CompletedThis study tested a self-guided online program for people with psoriasis. 348 adults were split into two groups: one got the app plus their regular treatment, the other got regular treatment alone. The main goal was to see if the app improved quality of life over 12 months.
Phase: NA • Sponsor: Gaia AG • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Ear device may tame arthritis pain without drugs
Symptom relief CompletedThis study tested whether a device that gently stimulates the vagus nerve through the ear could help control rheumatoid arthritis in one patient who had their spleen removed. The patient used the device at home for 24 months and visited the clinic every two months for checkups. T…
Phase: NA • Sponsor: Osteoflow Health Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Nurse sessions may help arthritis patients handle biologic drugs safely
Symptom relief CompletedThis study tested whether nurse-led consultations can help people with rheumatoid arthritis become more independent in managing their subcutaneous biotherapy. Many patients struggle to recognize warning signs and delay seeking help. The study enrolled 71 adults with rheumatoid ar…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Simple core workouts may tame pain and fatigue in kids with arthritis
Symptom relief CompletedThis study compares core stabilization exercises to a daily physical activity program in children aged 10-18 with juvenile spondyloarthropathy, a type of arthritis. The goal is to see if targeted core training can reduce pain, fatigue, and improve quality of life better than gene…
Phase: NA • Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Can mindfulness ease arthritis pain? small study seeks answers
Symptom relief CompletedThis completed pilot study tested an 8-week online mindfulness course in 38 people with rheumatoid arthritis. The goal was to see if patients liked the program, what barriers they faced, and how it might affect symptoms. Half the group took the course while the other half receive…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Cold therapy offers simple pain relief for arthritis patients
Symptom relief CompletedThis study tested whether applying cold to painful joints can reduce pain and improve quality of life in people with rheumatoid arthritis. 90 patients with active pain participated. The goal was to see if this simple, low-cost method could be a helpful addition to standard care.
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Zapping acupoints may ease period pain for autoimmune patients
Symptom relief CompletedThis study tested whether transcutaneous electrical acupoint stimulation (TEAS) — a gentle electrical pulse applied to specific points on the body — could reduce period pain and inflammation in women with autoimmune diseases like rheumatoid arthritis or lupus. Fifty-two women rec…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Dietary formula shows promise for psoriatic arthritis symptom relief
Symptom relief CompletedThis study tested whether a food formula containing medium-chain triglycerides (MCTs) and vegetable fibers could improve quality of life in 72 adults with psoriatic arthritis and low disease activity. Participants took the formula for 3 months while continuing their usual medicat…
Phase: NA • Sponsor: Dr. Schär AG / SPA • Aim: Symptom relief
Last updated Jun 27, 2026 12:10 UTC
-
Can a smartphone app ease rheumatoid arthritis symptoms?
Symptom relief CompletedThis study tested a mobile app designed to help people with rheumatoid arthritis manage their condition. 90 adults with stable treatment used the app for 12 weeks, while a control group received usual care. Researchers measured changes in disease activity and quality of life to s…
Phase: NA • Sponsor: Kırıkkale University • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Ancient remedy dharasana lep tested for pain relief in small study
Symptom relief CompletedThis study tested a treatment called Dharasana Lep in 35 adults with mild to moderate muscle or joint pain, including rheumatoid arthritis. The goal was to see if it safely reduces pain and improves movement. Participants used the treatment and reported their pain levels using si…
Phase: NA • Sponsor: NovoBliss Research Pvt Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Fasting for clearer skin? study tests Time-Restricted eating for psoriasis
Symptom relief CompletedThis study looked at whether intermittent fasting (eating only during certain hours) can reduce disease severity and improve quality of life for people with psoriasis and psoriatic arthritis. Sixty overweight adults were randomly assigned to either follow an intermittent fasting …
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Joint injection showdown: etanercept vs steroid for RA Flare-Ups
Symptom relief CompletedThis study tested whether an injection of etanercept, a targeted anti-inflammatory drug, works better than a standard steroid injection for sudden joint swelling in people with rheumatoid arthritis. 34 adults with active arthritis in a knee, wrist, ankle, or elbow took part. The …
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Cutting salt and sugar may tame steroid side effects
Symptom relief CompletedThis study looked at whether a diet low in salt and sugar can reduce common side effects of corticosteroid treatment, such as weight gain, high blood pressure, and diabetes. Fifty adults with autoimmune diseases or asthma who were starting high-dose corticosteroids were randomly …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Simple hand exercises show promise for arthritis sufferers
Symptom relief CompletedThis study tested a hand exercise program called SARAH in 6 women with rheumatoid arthritis. The program includes strengthening, stretching, and home exercises along with education. The goal was to see if it improves hand function and reduces pain.
Phase: NA • Sponsor: Federal University of Espirito Santo • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New study examines pain and adherence in patients switching to concentrated adalimumab
Symptom relief CompletedThis study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who switched from a standard to a higher-concentration form of adalimumab (AVT-02). Researchers measured injection site pain and how well patients stuck with their treatment over 180 days…
Sponsor: Jamp Pharma Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Walking by phone: new study tests arthritis pain relief without the gym
Symptom relief CompletedThis study tested a phone-based version of the Walk With Ease program for 267 adults with arthritis, gout, fibromyalgia, rheumatoid arthritis, osteoarthritis, or lupus. Participants followed a 6-week walking program delivered by phone, and researchers measured changes in pain, ph…
Phase: NA • Sponsor: University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Ancient cupping technique tested for back pain relief
Symptom relief CompletedThis study tested whether wet cupping therapy, an ancient practice where small cuts are made on the skin and cups are used to draw out a small amount of blood, can help people with ankylosing spondylitis, a type of arthritis that mainly affects the spine. Half of the 100 particip…
Phase: NA • Sponsor: Karabuk University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Remote Check-Ins may ease psoriatic arthritis symptoms
Symptom relief CompletedThis study tested whether two structured telemedicine visits, added between regular doctor appointments, could help people with psoriatic arthritis improve their quality of life and reduce disease impact. 101 adults with active symptoms took part. The visits focused on lifestyle …
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
App + fitbit helps arthritis patients take control
Symptom relief CompletedThis study tested a program called OPERAS that includes a web app for tracking symptoms and a physiotherapist who gives activity advice using a Fitbit. The goal was to see if it helps people with rheumatoid arthritis feel more confident managing their disease. 132 adults with rhe…
Phase: NA • Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can acthar calm RA flares? new study investigates
Symptom relief CompletedThis study looked at whether the drug Acthar can reduce inflammation and improve symptoms during a rheumatoid arthritis (RA) flare. Forty adults with RA who were having a flare took part. Researchers used ultrasound and disease activity scores to measure changes after treatment.
Phase: PHASE4 • Sponsor: Veena Ranganath, MD, MS • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Physiotherapy students test muscle relief techniques on themselves
Symptom relief CompletedThis study looked at how common muscle and posture problems are in physiotherapy students and whether a special physiotherapy program could help. 44 students with back pain and muscle tightness received treatments like trigger point release, stretching, and joint mobilization. Th…
Phase: NA • Sponsor: Charles University, Czech Republic • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Knee replacement recovery: which pain method works best?
Symptom relief CompletedThis study looked at two ways to manage pain after knee replacement surgery: a shot around the knee joint and a nerve block in the thigh. The goal was to see which method helps patients recover better and feel less pain. Sixty adults who had knee replacement took part, and their …
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could sound waves and special insoles ease RA foot pain?
Symptom relief CompletedThis completed study tested whether combining underwater ultrasound therapy with custom-made foot orthotics can help people with rheumatoid arthritis who have foot pain. Fifty-five participants received the treatments, and researchers measured pain, balance, and quality of life. …
Phase: NA • Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Tape trick eases back pain and improves balance in stiff spine disease
Symptom relief CompletedThis study tested whether kinesiology tape, applied to the back and shoulders, can reduce pain and improve posture, balance, and breathing in people with ankylosing spondylitis. 63 adults with the condition took part. The tape was compared with routine home exercises to see if it…
Phase: NA • Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Herbal combo shows promise for aching joints
Symptom relief CompletedThis study tested a dietary supplement containing Boswellia serrata, curcumin, and MSM in 100 adults with joint pain or stiffness. Participants took either the supplement or a placebo for a period, and researchers measured inflammation markers and arthritis symptoms using a stand…
Phase: NA • Sponsor: NXTVSION SDN. BHD. • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Could a probiotic blend ease early arthritis symptoms?
Symptom relief CompletedThis completed trial tested whether a medical food called SBD121, a mix of prebiotics and probiotics, could help manage symptoms of early rheumatoid arthritis. 143 adults with newly diagnosed RA (within one year) and taking methotrexate were randomly assigned to receive SBD121 or…
Phase: NA • Sponsor: Solarea Bio, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Desert sand baths may ease RA lung and pain symptoms
Symptom relief CompletedThis study tested whether Siwan sand therapy (warm sand baths followed by olive oil massage) could improve lung function, pain, and daily activity in people with rheumatoid arthritis. Thirty adults with moderate to severe RA were split into two groups: one received sand therapy f…
Phase: NA • Sponsor: Ahram Canadian University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Can a simple screening and exercise plan keep RA patients moving?
Symptom relief CompletedThis pilot study tested whether a care model called PREVAIL is practical and acceptable for adults with rheumatoid arthritis. The model includes a screening tool to identify activity limitations, a recommendation to the rheumatologist for exercise or physical therapy, and an onli…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Simple hand moves may ease arthritis pain and boost grip
Symptom relief CompletedThis study tested two hand therapy approaches—task-oriented training (like practicing daily activities) and Mulligan mobilization (a pain-free joint glide)—in 54 adults with rheumatoid arthritis. The goal was to see if these treatments could improve hand strength, function, and q…
Phase: NA • Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Exercise eases stiffness in ankylosing spondylitis patients
Symptom relief CompletedThis study tested whether a 9-week personalized physical training program using an exercise bike could help people with ankylosing spondylitis, a type of arthritis that affects the spine. Fifty-six patients participated, and researchers measured how many achieved a meaningful imp…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Tape it better? small study tests kinesiologic taping for knee arthritis pain
Symptom relief CompletedThis completed trial tested whether kinesiologic taping (a special elastic tape) applied to the knee can reduce pain, improve mobility, and lessen fear of movement in people with rheumatoid arthritis. Thirty adults aged 45 to 60 were randomly assigned to receive either real kines…
Phase: NA • Sponsor: Istanbul Rumeli University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Who should control your sedation during surgery? new study compares options
Symptom relief CompletedThis study looked at whether letting patients control their own sedation during arm surgery under regional anesthesia leads to higher satisfaction compared to having an anesthesiologist control it. 70 adults having upper limb orthopedic surgery were randomly assigned to either pa…
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Diet showdown: can keto or mediterranean ease psoriasis and joint pain?
Symptom relief CompletedThis study tested whether an 8-week ketogenic or Mediterranean diet could reduce inflammation in 26 adults with obesity, psoriasis, and psoriatic arthritis. Participants followed one of the two diets, and researchers measured skin severity (PASI score) and joint activity (DAPSA s…
Phase: NA • Sponsor: Attikon Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Can a 12-Week online program lift the mental health burden of psoriatic disease?
Symptom relief CompletedThis study tested a 12-week online program called Immune Strength for people with psoriasis or psoriatic arthritis. The program provided tips on stress, sleep, nutrition, and exercise, plus one-on-one email coaching from a wellness professional. Researchers wanted to see if this …
Phase: NA • Sponsor: Elaine Husni • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Home workouts tested for Arthritis-Lung condition
Symptom relief CompletedThis study tested whether a home-based exercise program, delivered online, could help people with rheumatoid arthritis who also have a lung condition called interstitial lung disease. Ten participants did breathing and trunk exercises via video. The goal was to see if it improved…
Phase: NA • Sponsor: Zülal TATAR • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Hands-On therapy eases jaw pain for rheumatoid arthritis patients
Symptom relief CompletedThis study tested two types of manual therapy (myofascial mobilization and joint mobilization) in 57 people with rheumatoid arthritis who also had jaw joint problems. Participants received therapy twice a week for six weeks, while a control group got no treatment. Both therapy gr…
Phase: NA • Sponsor: Sanko University • Aim: Symptom relief
Last updated Jun 26, 2026 16:49 UTC
-
New program aims to empower women with rheumatoid arthritis
Symptom relief CompletedThis completed trial tested a six-week group self-management program for women with rheumatoid arthritis. The program teaches skills to manage symptoms, stick to treatments, and improve quality of life. Researchers measured changes in self-efficacy, self-management behaviors, and…
Phase: NA • Sponsor: Universidad Nacional de Colombia • Aim: Symptom relief
Last updated Jun 26, 2026 16:48 UTC
-
Twin study seeks clues to rheumatic disease mysteries
Knowledge-focused CompletedThis study looks at families where one sibling has a rheumatic disease (like rheumatoid arthritis or lupus) and the other does not. Researchers compare their blood, genes, and environmental exposures to find clues about why one got sick. Over 1,000 participants are involved, incl…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Can your diet calm your arthritis? new study investigates
Knowledge-focused CompletedThis study is looking at how nutrition affects disease activity in people with rheumatic diseases like rheumatoid arthritis, lupus, and psoriatic arthritis. Researchers will measure the nutritional status of 460 participants using several different tools and compare it to how act…
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New turkish health survey could improve care for muscle and joint problems
Knowledge-focused CompletedThis study translated the Generic Functional Index, a questionnaire that measures how well people can do daily activities, into Turkish. Researchers tested it with 200 adults who have muscle or joint problems to see if it is accurate and reliable. The goal is to give Turkish-spea…
Sponsor: Istanbul Bilgi University • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Real-World study tests whether aggressive early treatment improves psoriatic arthritis outcomes
Knowledge-focused CompletedThis study follows people newly diagnosed with psoriatic arthritis (PsA) to see how a 'treat to target' approach works in everyday clinics. Participants receive standard care, often starting with methotrexate, and their disease activity is tracked over time. The goal is to unders…
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists hunt for genetic and environmental triggers of rare muscle diseases
Knowledge-focused CompletedThis study looked at 719 people, including patients with autoimmune connective tissue diseases like myositis, their blood relatives, and healthy volunteers. Researchers collected blood samples and medical histories to find genetic and environmental factors that may trigger these …
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists probe acid 'Pain Channels' in arthritic joints
Knowledge-focused CompletedThis completed study from France examined joint fluid from 20 people with arthritis to see if acid-sensing ion channels (ASICs) play a role in pain. Researchers wanted to find natural compounds that activate these channels during inflammation. The goal is to validate ASICs as tar…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Immune cell study could pave way for new arthritis treatments
Knowledge-focused CompletedThis study looked at a type of immune cell called B regulatory cells in 100 people—some healthy and some with rheumatoid arthritis (RA). The goal was to understand how these cells differ between the two groups and how they might help control the disease. By identifying unique fea…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
French study tracks Real-World use of TNF blockers in early arthritis
Knowledge-focused CompletedThis study followed 813 people with early rheumatoid arthritis in France to see how often and why doctors prescribe TNF blockers. Researchers tracked symptoms, joint damage, and treatment success over 5 years. The goal was to learn which patients benefit most and how well doctors…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New insights on TNF blockers alone for early arthritis
Knowledge-focused CompletedThis study followed 813 people with early rheumatoid arthritis in France to see how often doctors prescribe TNF blockers alone (without other arthritis drugs) and how well they work. Researchers tracked symptoms, joint damage, and how long patients stayed on treatment over 5 year…
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Are doctors following heart check rules for arthritis patients?
Knowledge-focused CompletedThis study looked at whether French doctors follow EULAR recommendations to check heart disease risk every year in patients with rheumatoid arthritis. Over 7000 patients were included. The goal was to see how often tests like blood sugar, cholesterol, and heart scans were prescri…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can text messages help arthritis patients take their meds?
Knowledge-focused CompletedThis study looked at three ways to help people with rheumatoid arthritis take their methotrexate medication as prescribed: usual doctor visits, text message reminders, or a chat with a pharmacist. The goal was to see which method works best to improve adherence. The study include…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Lung clues could unlock early rheumatoid arthritis detection
Knowledge-focused CompletedThis completed study looked at 340 people to understand how certain proteins in the lungs, called autoantibodies, might be linked to the start of rheumatoid arthritis (RA). Researchers collected sputum (mucus from the lungs) from people at risk for RA, those already diagnosed, an…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New arthritis drug copy tested in healthy people
Knowledge-focused CompletedThis study tested whether a new version of the arthritis drug abatacept (called KSHB002) works similarly to the approved drug Orencia. Three hundred healthy adults received a single injection of either the new drug or Orencia. Researchers measured drug levels in the blood, checke…
Phase: PHASE1 • Sponsor: Kashiv BioSciences, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Wearable sensors could revolutionize how we track ankylosing spondylitis
Knowledge-focused CompletedThis study tested whether wearable motion sensors can accurately measure spinal movement in people with ankylosing spondylitis (AS), a condition that causes back pain and stiffness. Forty participants (20 with AS and 20 healthy volunteers) wore sensors while performing everyday m…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Rheumatism Patients' COVID antibodies under the microscope
Knowledge-focused CompletedThis study followed 163 people with chronic inflammatory rheumatism (like rheumatoid arthritis) who had a recent COVID-19 infection. Researchers measured their antibody levels over two years to see how immunosuppressive drugs affect antibody persistence. The goal was to better un…
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Study reveals how well saudi doctors follow safety rules for common arthritis drug
Knowledge-focused CompletedThis study looked at whether healthcare professionals in Saudi Arabia are aware of and follow safety measures for the drug leflunomide, used for rheumatoid and psoriatic arthritis. Researchers surveyed 302 doctors and pharmacists to see if they received and read safety materials,…
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Pandemic stress hits hard for arthritis patients
Knowledge-focused CompletedThis completed study looked at how the COVID-19 pandemic and social distancing impacted the mental health of 259 adults with chronic inflammatory rheumatism (like rheumatoid arthritis or ankylosing spondylitis). Researchers used questionnaires to measure stress, depression, anxie…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Are women with autoimmune diseases getting the gynecological care they need?
Knowledge-focused CompletedThis study examined whether women with autoimmune diseases or inflammatory rheumatism receive proper gynecological follow-up, including cervical cancer screening and contraception advice. Researchers surveyed 318 women with conditions like lupus, rheumatoid arthritis, and Sjögren…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Thousands tracked: how safe is RINVOQ for arthritis in daily life?
Knowledge-focused CompletedThis study looked at the safety of the drug RINVOQ in over 4,200 Japanese adults with rheumatoid arthritis, a condition causing joint pain and swelling. Researchers reviewed medical records for three years to count serious infections and other side effects that happened during no…
Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Blood markers may predict arthritis drug success
Knowledge-focused CompletedThis study aimed to find blood markers that can predict whether the drug adalimumab will successfully treat ankylosing spondylitis after 6 months. Researchers analyzed blood samples from 50 adults starting adalimumab for the first time. The goal was to create an algorithm to help…
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Could the air you breathe trigger arthritis Flare-Ups?
Knowledge-focused CompletedThis completed study investigated whether air pollution affects flare-ups in people with rheumatoid arthritis, ankylosing spondylitis, or psoriatic arthritis. Researchers followed 86 patients for 6 months, asking them to complete weekly questionnaires about their symptoms. They a…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Scientists uncover immune cell clues in rare scleroderma
Knowledge-focused CompletedThis study looked at 235 people to understand how certain immune cells, called innate T cells, might be involved in systemic sclerosis (a rare disease that causes hardening of the skin and organs). Researchers compared patients with systemic sclerosis to those with other autoimmu…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Massive study reveals COVID-19 risks for autoimmune patients
Knowledge-focused CompletedThis study looked at over 13,000 people with chronic inflammatory rheumatism or autoimmune diseases who had or were suspected to have COVID-19. Researchers tracked how many developed severe COVID-19 requiring intensive care or leading to death. They also examined risk factors lik…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Rheumatoid arthritis Patients' arm function under the microscope
Knowledge-focused CompletedThis completed study from Turkey looked at how well rheumatoid arthritis patients can use their arms and hands. Researchers tested 26 patients using a pegboard and ring test for arm exercise, a hand dynamometer for grip strength, and a daily living test. The goal was to better un…
Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Could your diet trigger lupus? new study investigates
Knowledge-focused CompletedThis study measured phytoestrogens (plant-based compounds) in the blood and urine of 63 premenopausal women with active lupus, other autoimmune diseases, or no disease. Researchers also asked about diet and measured estradiol levels. The goal was to see if these dietary compounds…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can a simple blood test help rheumatoid arthritis patients get the right drug?
Knowledge-focused CompletedThis study looked at whether measuring drug levels and anti-drug antibodies in the blood of rheumatoid arthritis patients can help doctors make better treatment decisions. 52 patients starting adalimumab or certolizumab were randomly assigned to have their test results shared wit…
Phase: NA • Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Which health survey works best for joint disease? large study aims to find out
Knowledge-focused CompletedThis completed study looked at nearly 7,000 adults with inflammatory joint diseases like rheumatoid arthritis and psoriatic arthritis. Researchers compared two versions of a standard health survey (EQ-5D-3L and EQ-5D-5L) to see which one better measures health and quality of life…
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Blood sample study explores new target for inflammatory arthritis
Knowledge-focused CompletedThis study looked at blood samples from 24 people with axial spondyloarthritis (a type of inflammatory arthritis) and 12 healthy volunteers to understand how a receptor called KIR3DL2 contributes to inflammation. Researchers also tested whether a drug called IPH4102 could reduce …
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Tiny study probes Tofacitinib's hidden effects on body composition
Knowledge-focused CompletedThis completed study looked at how tofacitinib, a rheumatoid arthritis drug, changes body fat, muscle, and bone density in 10 patients. Researchers measured visceral fat, lean mass, and bone marrow fat before and after treatment. The goal was to gather early data, not to prove th…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
App and wearable track daily struggles of arthritis patients
Knowledge-focused CompletedThis study tested whether a smartphone app and a wearable activity tracker are practical and acceptable for people with inflammatory rheumatic diseases like rheumatoid arthritis and spondyloarthritis. Over 14 days, 50 participants answered short surveys on their phone and wore a …
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks COVID vaccine durability in chronic illness patients
Knowledge-focused CompletedThis completed study followed 360 adults and children with chronic respiratory and other medical conditions to see how their immune systems responded to COVID-19 vaccines over 18 months. Researchers measured antibody, T cell, and B cell levels before vaccination and every 3 month…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Nurse detectives: early warning system for arthritis flares?
Knowledge-focused CompletedThis study looked at whether regular nurse check-ins could spot the return of rheumatoid arthritis symptoms sooner than standard doctor visits. 51 adults with controlled arthritis on rituximab took part. The goal was to see if nurses could detect early signs of a flare, potential…
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Better scans could help measure spine fusion in ankylosing spondylitis
Knowledge-focused CompletedThis study looks at whether CT scans are better than regular X-rays for measuring how the spine stiffens and fuses in people with ankylosing spondylitis. Researchers will follow 63 adults over 4 years, using scans, blood tests, and flexibility measurements. The goal is to find a …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Combining traditional chinese medicine with standard care may ease RA and depression
Knowledge-focused CompletedThis completed study looked at whether adding an integrated care model—including traditional Chinese medicine—to standard treatment could lower inflammation and depressive symptoms in people with rheumatoid arthritis. Researchers measured blood markers of inflammation and used a …
Phase: NA • Sponsor: Dalin Tzu Chi General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Blood test may reveal hidden inflammation in back pain patients
Knowledge-focused CompletedThis study looked at 65 adults with ankylosing spondylitis, a type of arthritis that affects the spine. Researchers wanted to see if a blood test called the CALLY index could measure inflammation better than patient-reported symptoms. They reviewed medical records and compared th…
Sponsor: Bursa City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Rituximab infection risk under the microscope
Knowledge-focused CompletedThis completed study followed 73 people with autoimmune diseases like rheumatoid arthritis or multiple sclerosis who were starting treatment with rituximab. The goal was to track how many developed serious infections and to understand what factors increase that risk. Researchers …
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New breathing test studied in spine arthritis patients
Knowledge-focused CompletedThis study looked at chest expansion, lung function, and a new measure of breathing muscle strength called the S-index in 52 people with radiographic axial spondyloarthritis and healthy controls. The goal was to see if these measures differ between the two groups and if the S-ind…
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Knee surgery drain debate: new study compares blood loss with and without drain
Knowledge-focused CompletedThis study looked at whether placing a drain after knee replacement surgery affects how much hemoglobin drops and whether patients need a blood transfusion. 102 patients were randomly assigned to get a drain or not. The goal is to see if drains help or hurt in terms of blood loss…
Phase: NA • Sponsor: Shifa International Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Physios take on ER duty: study tests if they can replace doctors for back pain
Knowledge-focused CompletedThis study tested whether specially trained physiotherapists can safely diagnose and treat non-urgent muscle and joint pain in the emergency room, compared to standard care from doctors. 102 patients with back, neck, or shoulder pain were randomly assigned to either a physiothera…
Phase: NA • Sponsor: Bern University of Applied Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Sexual health in arthritis patients under the microscope
Knowledge-focused CompletedThis completed study examined the link between erectile dysfunction, nerve pain, disease activity, and daily function in 90 men with axial spondyloarthritis (a type of arthritis affecting the spine). Participants were either on anti-TNF drugs, NSAIDs, or were healthy volunteers. …
Sponsor: Altuğ Güner • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Can better Doctor-Patient talks improve rheumatoid arthritis care?
Knowledge-focused CompletedThis completed study tested whether training rheumatology clinicians in shared decision making helps veterans with rheumatoid arthritis. About 900 patients from VA clinics took part. The training taught doctors to acknowledge treatment options and involve patients in choices. Res…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Mind over pain? study probes resilience and body image in chronic illness
Knowledge-focused CompletedThis completed study looked at how psychological resilience and body image relate to pain in people with rheumatoid arthritis or fibromyalgia, compared to healthy volunteers. Researchers measured these factors using questionnaires in 124 adults. The goal was to better understand …
Sponsor: Samsun University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Tiny study hints Anti-TNF may improve sleep in ankylosing spondylitis
Knowledge-focused CompletedThis study followed 18 adults with active ankylosing spondylitis who were starting anti-TNF therapy for the first time. Researchers measured their sleep quality using overnight sleep tests and a questionnaire, and tracked their daily step counts with a wearable device. The goal w…
Sponsor: Samsun University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New MRI study reveals hidden neck muscle changes in ankylosing spondylitis
Knowledge-focused CompletedThis study used MRI to examine neck muscles in 158 people with ankylosing spondylitis (AS), a type of arthritis that affects the spine. Researchers measured muscle size, fat buildup, and spine alignment, comparing them to healthy controls. The goal was to better understand how AS…
Sponsor: Kayseri City Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
New tool helps patients and doctors choose psoriasis treatments together
Knowledge-focused CompletedThis study aimed to create and test a decision aid for people with psoriasis or psoriatic arthritis who are starting or switching treatments. Researchers worked with 37 patients and their doctors to design a tool that supports shared decision-making. The goal was to help patients…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Scientists test designer immune molecules in autoimmune diseases
Knowledge-focused CompletedThis study looked at whether specially engineered versions of a natural immune protein (IL-2) can selectively boost regulatory T cells, which help calm the immune system. Researchers took blood samples from 67 people with various autoimmune or inflammatory conditions and tested t…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Coaching eases tough move to adult rheumatology care
Knowledge-focused CompletedThis study tested whether coaching sessions are practical for young people with rheumatic diseases moving from pediatric to adult care. 26 participants received up to 8 coaching sessions covering self-advocacy, medication management, and future planning. The main goal was to see …
Phase: NA • Sponsor: McMaster University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Scientists uncover genetic clue behind arthritis joint destruction
Knowledge-focused CompletedThis study looked at a protein called MMP-9, which is involved in breaking down joint tissue in rheumatoid arthritis. Researchers measured genetic variations of MMP-9 in 60 people with active rheumatoid arthritis and compared them to healthy volunteers. The goal was to better und…
Phase: NA • Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Pregnancy's secret signals: could tiny molecules explain arthritis and lupus flares?
Knowledge-focused CompletedThis study looked at how small molecules called microRNAs change during pregnancy in women with rheumatoid arthritis or lupus. Researchers collected blood and urine samples before and after pregnancy from 50 women to see if these changes relate to disease activity. The goal is to…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
AstraZeneca tests new biologic in healthy volunteers – no cure expected
Knowledge-focused CompletedThis early-stage trial tested the safety and tolerability of an experimental drug called AZD1163 in 108 healthy volunteers. Participants received either the drug or a placebo by IV or injection, and researchers monitored side effects and how the drug moved through the body. Since…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
New test could reveal if arthritis patients are taking their meds
Knowledge-focused CompletedThis study looked at how the drug methotrexate and its main byproduct leave the body in people with rheumatoid arthritis. Researchers measured levels in urine to create a reference range. This could help doctors identify patients who are not taking their medication as prescribed.
Phase: NA • Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
RA study probes link between core endurance and hand function
Knowledge-focused CompletedThis study looked at how core endurance, finger grip strength, and fatigue relate to hand function in people with rheumatoid arthritis. Researchers measured these factors in 113 participants. The goal was to better understand these connections, which could help guide future treat…
Sponsor: Cumhuriyet University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Methotrexate off the hook? no lung harm found in RA study
Knowledge-focused CompletedThis study looked at 50 Egyptian patients with rheumatoid arthritis to see if methotrexate affects lung health. Half were taking methotrexate, and half were on other treatments. Researchers used lung function tests and CT scans to check for lung disease. They found no difference …
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Can lowering inflammation protect your heart? new study explores link in arthritis patients
Knowledge-focused CompletedThis study looked at how reducing inflammation might lower heart disease risk in people with rheumatoid arthritis. Researchers measured heart blood flow in 74 patients before and after treatment with certolizumab, a drug that fights inflammation. The goal was to see if better con…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Hip implant performance under review in completed study
Knowledge-focused CompletedThis study looked back at 54 people who had a hip replacement with a specific part called the CL TRAUMA cemented stem. The goal was to see if the part was safe and worked well. Researchers measured how well patients could move and if they had pain using a standard hip score.
Sponsor: Limacorporate S.p.a • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Gum disease linked to arthritis antibodies in new study
Knowledge-focused CompletedThis study explored the connection between gum disease severity and levels of certain antibodies (ACPAs) in people with rheumatoid arthritis. Researchers measured these antibodies in fluid from the gums before and after non-surgical gum treatment. The goal was to better understan…
Sponsor: Misr International University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Bone loss in menopause and arthritis: which treatments help?
Knowledge-focused CompletedThis study followed 82 postmenopausal women with rheumatoid arthritis to see how their bone density changed over time. Researchers compared different arthritis medications and osteoporosis treatments to understand which approaches best protect bone health. The goal was to gather …
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New study reveals how fatigue impacts psoriasis and arthritis patients
Knowledge-focused CompletedThis study looked at fatigue in 33 adults with psoriatic arthritis or psoriasis. Researchers used questionnaires to measure tiredness and see how it relates to disease severity and treatments. The goal was to better understand fatigue and its impact on quality of life.
Phase: NA • Sponsor: Centre Hospitalier Henri Duffaut - Avignon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC
-
Sound wave therapy shows promise for arthritis inflammation
Knowledge-focused CompletedThis study tested whether a non-invasive ultrasound device can reduce inflammation in people with inflammatory arthritis (psoriatic arthritis, rheumatoid arthritis, or ankylosing spondylitis). Sixteen participants received four sessions of focused ultrasound or a sham (placebo) t…
Phase: NA • Sponsor: Surf Therapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Survey reveals why rheumatism patients struggle with Follow-Up care
Knowledge-focused CompletedThis completed study surveyed 229 people with chronic inflammatory rheumatism (like rheumatoid arthritis) and their doctors to find out what makes it hard to follow care recommendations after a hospital visit. The goal was to identify barriers to good outpatient management. No tr…
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Researchers hunt for clues to predict spine arthritis progression
Knowledge-focused CompletedThis study looked at 70 people with spondyloarthritis, a type of inflammatory arthritis affecting the spine and joints. Researchers measured immune markers in the blood to see if they could predict how the disease would progress or how well patients would respond to treatment. Th…
Sponsor: Hospital for Special Surgery, New York • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Blood test for humira levels could personalize arthritis care
Knowledge-focused CompletedThis study looked at 69 adults with rheumatoid arthritis who were taking the drug adalimumab (Humira). Researchers measured drug levels in the blood over 6 months to see if they could predict who would respond well to treatment. The goal was to find a way to adjust doses early, i…
Phase: PHASE4 • Sponsor: University Hospital, Tours • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Hip implant performance tracked in 162 patients
Knowledge-focused CompletedThis study followed 162 people who received a G7 hip cup system during hip replacement surgery. Researchers measured pain, function, and hip movement using standard scores. The goal was to see how the device performs in everyday patients with arthritis or other joint problems.
Sponsor: Zimmer Biomet • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Large study checks cancer risk in arthritis drug abatacept
Knowledge-focused CompletedThis study looked at real-world data from over 140,000 people in Sweden with rheumatoid arthritis or psoriatic arthritis. Researchers tracked how many people developed different types of cancer while taking abatacept or other arthritis drugs. The goal was to better understand the…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
38,000 arthritis patients tracked: is abatacept safe Long-Term?
Knowledge-focused CompletedThis completed study looked at the safety of the arthritis drug abatacept in over 38,000 people with rheumatoid or psoriatic arthritis in Denmark. Researchers used a national health registry to track rates of cancers and other side effects. The goal was to better understand the d…
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Gene hunt for spine arthritis severity begins
Knowledge-focused CompletedThis study looks at how genes might influence the severity of ankylosing spondylitis, a type of arthritis that can fuse spine bones. Researchers will follow 299 adults with the condition for up to 5 years, tracking symptoms, spine flexibility, and X-rays. The goal is to identify …
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Gum treatment may ease arthritis inflammation, small study hints
Knowledge-focused CompletedThis study tested whether a deep cleaning of the gums (nonsurgical periodontal therapy) could lower inflammation and improve quality of life in 20 people who have both rheumatoid arthritis and gum disease. Researchers measured changes in immune markers, bacteria in the mouth, and…
Phase: NA • Sponsor: University of Malaya • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Exercise program shows promise for rheumatic pain and mood
Knowledge-focused CompletedThis study looked at how a special exercise approach called BETY affects people with rheumatic diseases (like arthritis) who have chronic pain. Researchers reviewed past records of 300 participants to see if BETY improved their physical function, mood, and quality of life compare…
Phase: NA • Sponsor: Eastern Mediterranean University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Can CRPS patients imagine movement? new study investigates
Knowledge-focused CompletedThis completed study compared how well people with complex regional pain syndrome (CRPS), people with other muscle or bone pain, and healthy individuals can imagine movements. Researchers used a questionnaire called the MIQ-RS to measure motor imagery skills. The goal was to see …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Pegboard puzzle: new test could track arm strength in arthritis patients
Knowledge-focused CompletedThis study tested whether a six-minute pegboard and ring test is a valid and reliable way to measure upper arm exercise capacity in people with rheumatoid arthritis. Forty patients completed the test along with other arm function measures. The goal is to see if this simple test c…
Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New study reveals how long patients stay on secukinumab for skin and joint conditions
Knowledge-focused CompletedThis completed study followed 127 adults with moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis who were already taking or starting secukinumab. Researchers observed them for two years to see how long the…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New drug LAD191 tested for safety in autoimmune patients
Knowledge-focused CompletedThis early-phase study tested the safety and tolerability of a new drug called LAD191 in 69 healthy adults and people with an autoimmune disease. Researchers gave single or multiple doses to see how the body processes the drug and if it causes side effects. The goal was to gather…
Phase: PHASE1 • Sponsor: Almirall, S.A. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Gut bacteria clues in new arthritis patients
Knowledge-focused CompletedThis study looked at the gut bacteria of 55 people—some newly diagnosed with rheumatoid arthritis and some without the disease. Researchers wanted to see if certain bacteria are more common in arthritis patients. The goal is to better understand how gut health might be linked to …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Robot or surgeon? study tests which knee surgery lasts longer
Knowledge-focused CompletedThis study looked at 192 people aged 50-85 with knee arthritis who needed knee replacement surgery. Half had computer-navigated surgery and half had the traditional technique. The goal was to see if computer guidance helps the new knee last longer, improves function, or reduces c…
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Scientists gather clues on mysterious immune defects
Knowledge-focused CompletedThis study collected blood, saliva, stool, urine, and skin samples from 19 people with unknown or poorly understood immune system problems. The goal was to learn how different parts of the immune system work together. No treatments or drugs were tested. Participants were followed…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Do arthritis patients know their heart risks? new study investigates
Knowledge-focused CompletedThis study looked at how much patients with rheumatoid arthritis or knee osteoarthritis know about cardiovascular disease risks. Researchers surveyed 120 adults aged 40 and older using a 28-item knowledge scale. The goal was to compare awareness between the two groups and identif…
Sponsor: Sisli Hamidiye Etfal Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Can a simple question curb doctor bias? new study tests individuation in rheumatology
Knowledge-focused CompletedThis completed pilot study tested whether training doctors to ask personalized questions (individuation) could improve care for Black and lower-income patients with rheumatic diseases like lupus and arthritis. Over 200 patients and their rheumatologists took part. The goal was to…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New screening tool aims to catch lung disease early in arthritis patients
Knowledge-focused CompletedThis study involved 1304 adults with rheumatoid arthritis who had at least two risk factors for interstitial lung disease (ILD), such as being male, a smoker, or over 60. Researchers used CT scans to develop a prediction model that helps doctors decide who should be screened for …
Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Can statins or other drugs fix cholesterol problems in autoimmune disease?
Knowledge-focused CompletedThis completed study examined why people with rheumatoid arthritis (RA) and lupus have a higher risk of heart attacks. Researchers collected blood samples from 176 participants and tested how statins and adenosine A2A receptor agonists affected cholesterol balance in cells. The g…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Can cutting salt calm rheumatoid arthritis? new study investigates
Knowledge-focused CompletedThis study looked at whether eating less salt can reduce inflammation, lower blood pressure, and decrease sodium levels in the skin of people with rheumatoid arthritis (RA). Researchers measured changes using MRI and disease activity scores in 18 adults with stable, moderate RA. …
Phase: NA • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Mind, spirit, and pain: new study explores what chronic pain patients really believe
Knowledge-focused CompletedThis study surveyed 116 adults with chronic pain at a rehabilitation clinic to understand how their pain beliefs, spiritual well-being, and attitudes toward complementary and alternative medicine are related. Participants filled out several questionnaires about their pain, mood, …
Sponsor: Gulseren Demir Karakilic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Hidden joint pain in nursing homes revealed
Knowledge-focused CompletedThis study looked at how common joint pain and swelling are in 100 nursing home residents aged 65 and older, both with and without dementia. Researchers performed a physical exam and used simple pain questions or a special checklist for those with severe dementia. The goal was to…
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Autoimmune disease and C-Section: new study targets bleeding risks
Knowledge-focused CompletedThis completed study looked at 1,000 women with autoimmune diseases (like lupus) who had a C-section. Researchers wanted to find out how many had severe bleeding (postpartum hemorrhage) and what factors increased that risk. By analyzing medical records, they hope to identify high…
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New arthritis drug put to the sun safety test
Knowledge-focused CompletedThis study tested whether the experimental drug SAR441566, being developed for rheumatoid arthritis, makes skin more sensitive to ultraviolet (UV) light. Sixty healthy adults aged 18 to 55 received either the drug, a placebo, or ciprofloxacin (a known sun-sensitizer). Researchers…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:51 UTC
-
Can a simple questionnaire make virtual rheumatoid arthritis visits better?
Knowledge-focused CompletedThis study tested whether a questionnaire called the Rheumatoid Arthritis Impact of Disease (RAID) could help doctors make better decisions during virtual consultations. 70 patients with rheumatoid arthritis participated. The goal was to see if using this tool reduced the need fo…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:24 UTC
-
Psoriasis meds may quietly shield arteries, small study hints
Knowledge-focused CompletedThis study checked if newer psoriasis drugs (IL17/23 inhibitors) also improve artery stiffness, a sign of heart disease. Researchers followed 66 people with moderate-to-severe psoriasis for a year, measuring pulse wave velocity (PWV) and other markers. The goal was to see if thes…
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:40 UTC
-
Rheumatoid arthritis study tests Nurse-Led care and patient Self-Assessment
Knowledge-focused CompletedThis completed trial looked at whether a center focused on standard care for rheumatoid arthritis (RA) can improve how patients manage their disease. Nearly 1,000 adults with stable RA took part. The study tested two things: a nurse visit to check for and treat common RA-related …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:37 UTC